CVS Health Corporation (CVS)
CVS Health Statistics
Share Statistics
CVS Health has 1.26B shares outstanding. The number of shares has increased by 0% in one year.
Shares Outstanding | 1.26B |
Shares Change (YoY) | 0% |
Shares Change (QoQ) | 0.03% |
Owned by Institutions (%) | 82.88% |
Shares Floating | 1.26B |
Failed to Deliver (FTD) Shares | 9.19K |
FTD / Avg. Volume | 0.08% |
Short Selling Information
The latest short interest is 16.99M, so 1.35% of the outstanding shares have been sold short.
Short Interest | 16.99M |
Short % of Shares Out | 1.35% |
Short % of Float | 1.35% |
Short Ratio (days to cover) | 1.04 |
Valuation Ratios
The PE ratio is 12.25 and the forward PE ratio is 9.48. CVS Health's PEG ratio is -0.28.
PE Ratio | 12.25 |
Forward PE | 9.48 |
PS Ratio | 0.15 |
Forward PS | 0.2 |
PB Ratio | 0.75 |
P/FCF Ratio | 8.93 |
PEG Ratio | -0.28 |
Enterprise Valuation
CVS Health Corporation has an Enterprise Value (EV) of 172.65B.
EV / Earnings | 37.42 |
EV / Sales | 0.46 |
EV / EBITDA | 12.6 |
EV / EBIT | 20.27 |
EV / FCF | 27.29 |
Financial Position
The company has a current ratio of 0.81, with a Debt / Equity ratio of 1.1.
Current Ratio | 0.81 |
Quick Ratio | 0.6 |
Debt / Equity | 1.1 |
Total Debt / Capitalization | 52.32 |
Cash Flow / Debt | 0.11 |
Interest Coverage | 2.88 |
Financial Efficiency
Return on equity (ROE) is 0.06% and return on capital (ROIC) is 4%.
Return on Equity (ROE) | 0.06% |
Return on Assets (ROA) | 0.02% |
Return on Capital (ROIC) | 4% |
Revenue Per Employee | $1,702,324.2 |
Profits Per Employee | $21,068.49 |
Employee Count | 219,000 |
Asset Turnover | 1.47 |
Inventory Turnover | 17.75 |
Taxes
Income Tax | 1.56B |
Effective Tax Rate | 0.25 |
Stock Price Statistics
The stock price has increased by -14.21% in the last 52 weeks. The beta is 0.53, so CVS Health's price volatility has been higher than the market average.
Beta | 0.53 |
52-Week Price Change | -14.21% |
50-Day Moving Average | 60.1 |
200-Day Moving Average | 58 |
Relative Strength Index (RSI) | 61.87 |
Average Volume (20 Days) | 11.34M |
Income Statement
In the last 12 months, CVS Health had revenue of 372.81B and earned 4.61B in profits. Earnings per share was 3.66.
Revenue | 372.81B |
Gross Profit | 51.4B |
Operating Income | 8.52B |
Net Income | 4.61B |
EBITDA | 13.7B |
EBIT | 8.52B |
Earnings Per Share (EPS) | 3.66 |
Balance Sheet
The company has 8.59B in cash and 82.92B in debt, giving a net cash position of -74.33B.
Cash & Cash Equivalents | 8.59B |
Total Debt | 82.92B |
Net Cash | -74.33B |
Retained Earnings | 62.84B |
Total Assets | 253.22B |
Working Capital | -15.96B |
Cash Flow
In the last 12 months, operating cash flow was 9.11B and capital expenditures -2.78B, giving a free cash flow of 6.33B.
Operating Cash Flow | 9.11B |
Capital Expenditures | -2.78B |
Free Cash Flow | 6.33B |
FCF Per Share | 5.02 |
Margins
Gross margin is 13.79%, with operating and profit margins of 2.28% and 1.24%.
Gross Margin | 13.79% |
Operating Margin | 2.28% |
Pretax Margin | 1.65% |
Profit Margin | 1.24% |
EBITDA Margin | 3.68% |
EBIT Margin | 2.28% |
FCF Margin | 1.7% |
Dividends & Yields
CVS pays an annual dividend of $2.66, which amounts to a dividend yield of 4.94%.
Dividend Per Share | $2.66 |
Dividend Yield | 4.94% |
Dividend Growth (YoY) | 0% |
Payout Ratio | 72.68% |
Earnings Yield | 5.44% |
FCF Yield | 7.45% |
Analyst Forecast
The average price target for CVS is $73, which is 8.4% higher than the current price. The consensus rating is "Buy".
Price Target | $73 |
Price Target Difference | 8.4% |
Analyst Consensus | Buy |
Analyst Count | 17 |
Stock Splits
The last stock split was on Jun 7, 2005. It was a forward split with a ratio of 2:1.
Last Split Date | Jun 7, 2005 |
Split Type | forward |
Split Ratio | 2:1 |
Scores
Altman Z-Score | 2.16 |
Piotroski F-Score | 6 |